We welcome the European Commissions (EC) initiative to develop an ambitious and comprehensive Biotech Act that positions Europe as a global leader in biotechnology. We ask the EC to take a focused and tailored approach to healthcare biotechnology within the broader EU biotech strategy.
GSK
Company · United Kingdom · EU Transparency Register 7990322925-77
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 925 companies & groups on this site, they rank #704 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- American Chamber of Commerce to the European Union (AmChamEU)
- European Federation of Pharmaceutical Industries and Associations (EFPIA)
- Vaccines Europe (VE)
- International Pharmaceutical Aerosol Consortium (IPAC)
- Digital Europe →
- MedTech Europe →
- European Policy Centre (EPC)
- Friends of Europe
- European Roundtable for Industry (ERT) →
- British Chamber of Commerce EU & Belgium →
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Companies & groups
- Head office
- London, United kingdom
- EU office
- Brussels
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track GSK in PolicySpeak: request access →
Work at GSK? so we know who speaks for it.
Their record over time
GSK filed 1 position on 10 Jun 2025, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from GSK’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.